Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

Papers filed in $67-billion Canadian class action against Purdue Pharma

B.C. is leading the Canadian charge against the U.S.-based drugmaker behind OxyContin in a multi-billion dollar class action lawsuit and as Nadia Stewart reports, it could be years before provinces see any of the money they’re suing Purdue Pharma for.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article